Wells Fargo & Company Chroma Dex Corp. Put Options Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CDXC
# of Institutions
82Shares Held
16.4MCall Options Held
91.7KPut Options Held
18.9K-
Vanguard Group Inc Valley Forge, PA3.39MShares$11 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.12MShares$10.2 Million0.0% of portfolio
-
Tieton Capital Management, LLC Yakima, WA2.97MShares$9.68 Million4.5% of portfolio
-
Iconiq Capital, LLC San Francisco, CA1.3MShares$4.23 Million0.07% of portfolio
-
Geode Capital Management, LLC Boston, MA1.13MShares$3.69 Million0.0% of portfolio
About ChromaDex Corp.
- Ticker CDXC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,350,896
- Market Cap $223M
- Description
- ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...